Compare Agilent Technologies Inc (A) vs Tesla, Inc. (TSLA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Tesla, Inc. — how do they compare? Agilent Technologies Inc trades at $128.65 (market cap $37.04B), while Tesla, Inc. trades at $390.68 (market cap $1.51T). The key difference: Tesla, Inc. is far larger — about 40.8× Agilent Technologies Inc's market cap, and Agilent Technologies Inc pays a 0.78% dividend while Tesla, Inc. pays none. Which is the better fit depends on your goals.
| A | TSLA | |
|---|---|---|
Market Cap | $37.04B | $1.51T |
Sector | Health | Consumer Cyclical |
52-Week High | $157.20 | $489.88 |
52-Week Low | $110.24 | $295.88 |
Enterprise Value | $38.59B | $1.48T |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Tesla (TSLA) trades at $395.04, down 5.89% over the past 24 hours, with a neutral technical signal and mixed earnings history. The stock shows elevated valuation ratios (P/E 369.63, P/S 14.54) against declining profitability margins (net income margin 3.95% in 2025). Recent news highlights regulatory approval for self-driving software in Europe and a potential cheaper EV model, while Q1 2026 deliveries missed estimates amid competitive pressures.
Outlook remains bifurcated: long-term growth depends on AI and autonomy execution, but near-term risks include softening auto demand and high valuation. Analyst consensus price target is $429.91, implying upside, yet sentiment is cautious with 39.51% buy ratings. Investors face volatility from execution risks and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
